The sensitivity of a polA strain to the antibacterial activity of mutagens and carcinogens may be increased by inserting one or both of the following characteristics, a lexA mutation or the R391 bacterial plasmid. The effects of the lexA mutation and the plasmid appear to be additive. The differential sensitivity of a polA lexA (R391) strain could be adapted as a preliminary screening test for mutagens and potential carcinogens.
The differential sensitivity of repair-deficient Escherichia coli strains has been proposed as an alternative to mutagenesis tests for inferring the interaction between different compounds and bacterial DNA (1, 7, 13' 1,5, 16).
Strains lacking polymerase I activity (15, 16) , excision repair (1), or recombination repair (7, 13) have been used. In principle, strains carrying multiple defects could be very suitable for this kind of test. Some combinations of defects, however, are not viable, like recA polA (19), whereas others are not additive, like uvrA poLA (10) .
In the present paper it is shown that the sensitivity of a poL4 strain may be increased by inserting one or both of the following characteristics, a lexA mutation or the R391 bacterial plasmid (4) .
lexA strains lack the function of one sector of postreplication repair (12) , and the R391 plasmid was chosen because it is the only one, among more than 70 plasmids tested, that has a mutator effect and increases the UV sensitivity of strains carrying it (unpublished data). RESULTS AND DISCUSSION Figure 1 shows the diameter of the halo of inhibition produced with the above strains by various amounts of known mutagens and carcinogens (8) (methyl methane sulfonate, ethyl methane sulfonate, mitomycin C, metronidazole). As expected, according to previous reports (15, 16) , strain TM930 showed larger inhibition zones than the wild-type strain, due to the higher (11), and daunomycin (8, 14) . It is worth noting at this point that the antibacterial activity of a drug not mediated by DNA interaction generated equal inhibition zones in all strains including WP2 wild type. Fig. 2 . In this way, the effect of drugs requiring metabolic microsomal activation may be tested, as shown in Table 2 for 2-amino-fluorene. Tests based on differential sensitivity of strains lacking repair functions have two major advantages over tests for mutagenicity, e.g., the Salmonella/microsome assay (1, 2) . First, being more simple to perform, at least when carried out as a spot test, they may be used as prescreening tests for identifying substances to be submitted for more sophisticated test systems. Second, they may offer the main evidence for the interaction of a substance with bacterial DNA for strongly bactericidal agents.
MATERIALS AND METHODS
From the above results it is clear that, using a strain such as TM1080 with multiple defects and carrying the mutator plasmid R391, a quick and easy test could be adopted as a preliminary screening test for mutagens and potential carcinogens. Validation of this test on a wider range of substances is in progress.
